Source: Medical Device News Magazine

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

100-250

CEO

Andrew Cavey

CEO Approval Rating

- -/100

ITM is a Germany-based biotechnology company that researches and develops radiopharmaceuticals and radioisotopes for the treatment of cancer.

Celine Wilke joined ITM as Chief Medical Officer